STOCK TITAN

Airsculpt Technologies, Inc. Financials

AIRS
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Airsculpt Technologies, Inc. (AIRS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 22 / 100
Financial Profile 22/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
5

Airsculpt Technologies, Inc. has an operating margin of -7.6%, meaning the company retains $-8 of operating profit per $100 of revenue. This below-average margin results in a low score of 5/100, suggesting thin profitability after operating expenses. This is down from -1.0% the prior year.

Growth
7

Airsculpt Technologies, Inc.'s revenue declined 15.8% year-over-year, from $180.3M to $151.8M. This contraction results in a growth score of 7/100.

Leverage
90

Airsculpt Technologies, Inc. carries a low D/E ratio of 0.58, meaning only $0.58 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
5

Airsculpt Technologies, Inc.'s current ratio of 0.55 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 5/100, which could limit financial flexibility.

Cash Flow
26

While Airsculpt Technologies, Inc. generated $3.1M in operating cash flow, capex of $2.4M consumed most of it, leaving $692K in free cash flow. This results in a low score of 26/100, reflecting heavy capital investment rather than weak cash generation.

Returns
0

Airsculpt Technologies, Inc. generates a -13.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -10.4% the prior year.

Piotroski F-Score Weak
3/9

Airsculpt Technologies, Inc. passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
-0.27x

For every $1 of reported earnings, Airsculpt Technologies, Inc. generates $-0.27 in operating cash flow ($3.1M OCF vs -$11.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk
-1.9x

Airsculpt Technologies, Inc. earns $-1.9 in operating income for every $1 of interest expense (-$11.6M vs $6.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$151.8M
YoY-15.8%
5Y CAGR+19.3%

Airsculpt Technologies, Inc. generated $151.8M in revenue in fiscal year 2025. This represents a decrease of 15.8% from the prior year.

EBITDA
$1.2M
YoY-87.9%
5Y CAGR-40.0%

Airsculpt Technologies, Inc.'s EBITDA was $1.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 87.9% from the prior year.

Net Income
-$11.7M
YoY-41.4%

Airsculpt Technologies, Inc. reported -$11.7M in net income in fiscal year 2025. This represents a decrease of 41.4% from the prior year.

EPS (Diluted)
$-0.19
YoY-35.7%

Airsculpt Technologies, Inc. earned $-0.19 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 35.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$692K
YoY+126.0%
5Y CAGR-41.7%

Airsculpt Technologies, Inc. generated $692K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 126.0% from the prior year.

Cash & Debt
$8.4M
YoY+2.6%
5Y CAGR-4.0%

Airsculpt Technologies, Inc. held $8.4M in cash against $50.6M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
71M
YoY+20.9%

Airsculpt Technologies, Inc. had 71M shares outstanding in fiscal year 2025. This represents an increase of 20.9% from the prior year.

Margins & Returns

Gross Margin
59.4%
YoY-1.0pp
5Y CAGR-3.2pp

Airsculpt Technologies, Inc.'s gross margin was 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the prior year.

Operating Margin
-7.6%
YoY-6.6pp
5Y CAGR-23.6pp

Airsculpt Technologies, Inc.'s operating margin was -7.6% in fiscal year 2025, reflecting core business profitability. This is down 6.6 percentage points from the prior year.

Net Margin
-7.7%
YoY-3.1pp
5Y CAGR-19.8pp

Airsculpt Technologies, Inc.'s net profit margin was -7.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.1 percentage points from the prior year.

Return on Equity
-13.3%
YoY-2.9pp
5Y CAGR-19.4pp

Airsculpt Technologies, Inc.'s ROE was -13.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$2.4M
YoY-82.8%
5Y CAGR-8.2%

Airsculpt Technologies, Inc. invested $2.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 82.8% from the prior year.

AIRS Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $35.0M-20.5% $44.0M+11.8% $39.4M+0.5% $39.2M-7.9% $42.5M-16.6% $51.0M+7.1% $47.6M0.0% $47.6M
Cost of Revenue $14.9M-13.6% $17.2M+7.8% $15.9M-4.8% $16.7M-5.7% $17.8M-5.6% $18.8M+4.4% $18.0M+1.0% $17.9M
Gross Profit $20.1M-24.9% $26.8M+14.5% $23.4M+4.4% $22.4M-9.5% $24.8M-23.0% $32.2M+8.8% $29.6M-0.5% $29.7M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $19.5M-13.9% $22.7M+4.1% $21.8M-6.8% $23.4M-8.4% $25.5M-25.6% $34.3M+117.5% $15.8M-38.4% $25.6M
Operating Income -$9.8M-1340.5% $786K+149.5% -$1.6M+61.5% -$4.1M-11.2% -$3.7M+25.4% -$5.0M-145.2% $11.0M+684.3% $1.4M
Interest Expense $1.4M-9.9% $1.6M-3.9% $1.6M+1.0% $1.6M+1.1% $1.6M+5.0% $1.5M-1.1% $1.5M+49.8% $1.0M
Income Tax -$1.6M-789.2% -$185K+49.6% -$367K+48.0% -$706K-196.3% $733K+122.3% -$3.3M-195.3% $3.5M-30.4% $5.0M
Net Income -$9.5M-1509.5% -$591K+79.2% -$2.8M+43.4% -$5.0M+16.7% -$6.0M-88.4% -$3.2M-153.2% $6.0M+231.8% -$4.6M
EPS (Diluted) $-0.15-1400.0% $-0.01+80.0% $-0.05 N/A $-0.10-66.7% $-0.06-160.0% $0.10 N/A

AIRS Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $185.9M-6.3% $198.4M-2.4% $203.3M-3.2% $210.0M+0.8% $208.2M-0.9% $210.1M+3.6% $202.7M-0.6% $204.0M
Current Assets $12.2M-25.5% $16.4M+7.2% $15.3M-10.6% $17.1M+32.8% $12.9M-40.6% $21.7M+44.7% $15.0M-6.1% $16.0M
Cash & Equivalents $5.4M-34.0% $8.2M+47.5% $5.6M-32.6% $8.2M+37.9% $6.0M-39.5% $9.9M-10.1% $11.0M+6.9% $10.3M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $81.7M0.0% $81.7M0.0% $81.7M0.0% $81.7M0.0% $81.7M0.0% $81.7M0.0% $81.7M0.0% $81.7M
Total Liabilities $103.8M-3.2% $107.2M-14.9% $125.9M-3.7% $130.7M+4.0% $125.7M+0.5% $125.1M+4.9% $119.2M-0.7% $120.0M
Current Liabilities $24.2M-6.5% $25.8M-3.6% $26.8M-6.4% $28.6M+12.9% $25.3M+0.9% $25.1M+15.4% $21.8M+7.1% $20.3M
Long-Term Debt $51.9M-2.4% $53.2M-17.2% $64.3M-1.8% $65.5M-1.5% $66.4M-1.7% $67.5M-1.4% $68.5M-1.4% $69.5M
Total Equity $82.1M-9.9% $91.2M+17.9% $77.3M-2.5% $79.3M-3.9% $82.5M-2.9% $85.0M+1.8% $83.5M-0.6% $84.0M
Retained Earnings -$40.8M-30.4% -$31.2M-1.9% -$30.6M-10.2% -$27.8M-22.1% -$22.8M-36.1% -$16.7M-23.7% -$13.5M+30.8% -$19.6M

AIRS Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow -$225K-104.5% $5.0M+474.2% $868K-68.0% $2.7M+48.3% $1.8M-46.8% $3.4M+2.3% $3.4M-30.8% $4.9M
Capital Expenditures $180K-32.1% $265K-86.1% $1.9M-46.1% $3.5M-28.0% $4.9M+21.9% $4.0M+157.2% $1.6M-14.5% $1.8M
Free Cash Flow -$405K-108.6% $4.7M+556.8% -$1.0M-26.7% -$815K+73.4% -$3.1M-432.8% -$576K-131.9% $1.8M-40.7% $3.0M
Investing Cash Flow -$180K+32.1% -$265K+86.1% -$1.9M+46.1% -$3.5M+28.0% -$4.9M-21.9% -$4.0M-157.2% -$1.6M+14.5% -$1.8M
Financing Cash Flow -$2.4M-14.2% -$2.1M-26.3% -$1.6M-153.6% $3.1M+473.1% -$825K-56.5% -$527K+51.9% -$1.1M+23.7% -$1.4M
Dividends Paid $0 $0 $0-100.0% $238K $0-100.0% $14K+7.7% $13K-92.7% $179K
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AIRS Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin 57.5%-3.4pp 60.9%+1.4pp 59.5%+2.2pp 57.3%-1.0pp 58.2%-4.8pp 63.1%+1.0pp 62.1%-0.4pp 62.5%
Operating Margin -27.9%-29.6pp 1.8%+5.8pp -4.0%+6.5pp -10.5%-1.8pp -8.7%+1.0pp -9.8%-32.9pp 23.1%+20.2pp 2.9%
Net Margin -27.2%-25.8pp -1.3%+5.9pp -7.2%+5.6pp -12.8%+1.3pp -14.2%-7.9pp -6.3%-18.9pp 12.7%+22.3pp -9.6%
Return on Equity -11.6%-10.9pp -0.7%+3.0pp -3.7%+2.7pp -6.3%+1.0pp -7.3%-3.6pp -3.8%-11.0pp 7.2%+12.7pp -5.5%
Return on Assets -5.1%-4.8pp -0.3%+1.1pp -1.4%+1.0pp -2.4%+0.5pp -2.9%-1.4pp -1.5%-4.5pp 3.0%+5.2pp -2.2%
Current Ratio 0.51-0.1 0.64+0.1 0.57-0.0 0.60+0.1 0.51-0.4 0.86+0.2 0.69-0.1 0.79
Debt-to-Equity 0.63+0.0 0.58-0.2 0.830.0 0.83+0.0 0.80+0.0 0.79-0.0 0.820.0 0.83
FCF Margin -1.2%-11.9pp 10.7%+13.3pp -2.6%-0.5pp -2.1%+5.1pp -7.2%-6.1pp -1.1%-4.9pp 3.8%-2.6pp 6.4%

Note: The current ratio is below 1.0 (0.55), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Airsculpt Technologies, Inc. (AIRS) reported $151.8M in total revenue for fiscal year 2025. This represents a -15.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Airsculpt Technologies, Inc. (AIRS) revenue declined by 15.8% year-over-year, from $180.3M to $151.8M in fiscal year 2025.

No, Airsculpt Technologies, Inc. (AIRS) reported a net income of -$11.7M in fiscal year 2025, with a net profit margin of -7.7%.

Airsculpt Technologies, Inc. (AIRS) reported diluted earnings per share of $-0.19 for fiscal year 2025. This represents a -35.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Airsculpt Technologies, Inc. (AIRS) had EBITDA of $1.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Airsculpt Technologies, Inc. (AIRS) had $8.4M in cash and equivalents against $50.6M in long-term debt.

Airsculpt Technologies, Inc. (AIRS) had a gross margin of 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Airsculpt Technologies, Inc. (AIRS) had an operating margin of -7.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Airsculpt Technologies, Inc. (AIRS) had a net profit margin of -7.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Airsculpt Technologies, Inc. (AIRS) has a return on equity of -13.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Airsculpt Technologies, Inc. (AIRS) generated $692K in free cash flow during fiscal year 2025. This represents a 126.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Airsculpt Technologies, Inc. (AIRS) generated $3.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Airsculpt Technologies, Inc. (AIRS) had $187.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Airsculpt Technologies, Inc. (AIRS) invested $2.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Airsculpt Technologies, Inc. (AIRS) had 71M shares outstanding as of fiscal year 2025.

Airsculpt Technologies, Inc. (AIRS) had a current ratio of 0.55 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Airsculpt Technologies, Inc. (AIRS) had a debt-to-equity ratio of 0.58 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Airsculpt Technologies, Inc. (AIRS) had a return on assets of -6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Airsculpt Technologies, Inc. (AIRS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Airsculpt Technologies, Inc. (AIRS) has an earnings quality ratio of -0.27x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Airsculpt Technologies, Inc. (AIRS) has an interest coverage ratio of -1.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Airsculpt Technologies, Inc. (AIRS) scores 22 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top